Eli Lilly
American pharmacist, Union Army officer, businessman, philanthropist (1838–1898)
📊 Rating
49 news mentions · 👍 0 likes · 👎 0 dislikes
📌 Topics
- Pharmaceuticals (6)
- Clinical Trials (3)
- Stock Market (3)
- Pharmaceutical Competition (2)
- Healthcare Disruption (2)
- Corporate Partnership (2)
- Market Competition (2)
- Market Analysis (2)
- Pharmaceutical innovation (2)
- Telehealth Expansion (1)
- Weight Loss Pharmaceuticals (1)
- Digital Healthcare Access (1)
🏷️ Keywords
Eli Lilly (25) · Zepbound (5) · GLP-1 (3) · Novo Nordisk (3) · obesity drug (3) · pharmaceutical market (3) · Taltz (3) · pharmaceuticals (3) · weight loss drug (2) · obesity treatment (2) · Amazon Pharmacy (2) · same-day delivery (2) · GLP-1 agonist (2) · Foundayo (2) · FDA approval (2) · obesity pill (2) · weight-loss drugs (2) · biotechnology (2) · supply chain (2) · Nvidia (2)
📖 Key Information
📰 Related News (49)
-
-
🇺🇸 Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, We...
-
-
🇺🇸 Amazon to stock Lilly's new weight-loss pill at U.S. kiosks, offer same-day delivery
Amazon Pharmacy began delivering GLP-1 medications in 2021, but does not stock injectable versions of the drugs in kiosks because they need to be refr...
-
-
🇺🇸 FDA approves new weight loss pill from Eli Lilly
FDA approves new weight loss pill from Eli Lilly...
-
🇺🇸 FDA approves Eli Lilly weight loss pill
The FDA approved a new GLP-1 drug from Eli Lilly. Dr. Jon LaPook breaks it down....
-
🇺🇸 FDA grants speedy approval to Eli Lilly weight-loss pillThe Federal Drug Administration (FDA) has approved a new once-daily weight-loss pill from Eli Lilly, adding to the bevy of GLP-1 medications available...
-
-
🇺🇸 FDA grants speedy approval to Eli Lilly's weight-loss pill for obesityThe Food and Drug Administration's decision Wednesday means patients in the United States will soon have access to a second daily oral medication to t...
-
🇬🇧 US approves new oral weight-loss pill developed by Eli Lilly<p>Called Foundayo, the tablet becomes the second one to receive FDA’s green light after Novo Nordisk’s Wegovy</p><p>The US Food and Drug Administrati...
-
🇺🇸 Eli Lilly secures long-awaited FDA approval for its obesity pill. Here's what to know
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading....
-
🇺🇸 Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says
Eli Lilly opposes the White House's push to codify "most favored nation" drug pricing into law, CEO Dave Ricks said in an interview with CNBC....
-
🇺🇸 Eli Lilly wins US approval for weight-loss drug in pill formNew drug Foundayo sets up battle with Novo Nordisk for oral obesity drugs...
-
🇺🇸 F.D.A. Approves New Eli Lilly Obesity Pill, FoundayoThe drug, made by Eli Lilly, could offer a more convenient option for patients who want to avoid injections....
-
🇺🇸 Stocks making the biggest moves midday: Eli Lilly, Hasbro, Philip Morris, Intel, Micron & more
These are the stocks posting the largest moves in midday trading....
-
🇺🇸 FDA approves lower-cost daily weight loss pill from Eli LillyA new daily pill, called Foundayo, is the second oral GLP-1 to reach the market in recent months, following the FDA approval of Novo Nordisk’s Wegovy ...
-
🇺🇸 FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market
The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market....
-
-
-
🇺🇸 Stocks soar on hopes of Iran war resolution — plus, Lilly takes a big swing in sleep disorders
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading....
-
-
🇺🇸 Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 BillionEli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug....
-
🇺🇸 Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake...
-
🇺🇸 Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly
Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the ...
-
🇺🇸 Eli Lilly to buy Centessa in $6.3 billion deal for sleep medicines
Eli Lilly said on Tuesday it would buy Centessa Pharmaceuticals in a deal valued at about $6.3 billion....
-
-
🇺🇸 U.S. executives, from Apple to Eli Lilly, revamp their push into the world's second-largest economy at the China Development Forum
More than 80 global executives traveled to Beijing this weekend for the state-organized China Development Forum....
-
-
🇺🇸 Eli Lilly's new shot shows solid weight loss in study — plus, a way for Nvidia to perk up
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET....
-
🇺🇸 Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforg...
-
🇺🇸 Eli Lilly shares slide after a bearish Wall Street analyst call — here's our view
"On balance, we do not like the risk/reward balance in Lilly shares," the analysts wrote....
-
🇺🇸 Stocks making the biggest moves midday: Mosaic, Tencent Music, Delta Air Lines, Uber, Eli Lilly & more
Here are some of the stocks making big headlines in midday trading....
-
🇺🇸 Eli Lilly catches a downgrade as HSBC warns of an overhyped obesity drug market
HSBC signals a potential cooling period for the red-hot obesity drug trade....
-
🇺🇸 Stocks making the biggest moves premarket: Nvidia, Delta Air Lines, Eli Lilly & more
These are the stocks posting the largest moves premarket....
-
-
🇺🇸 Jim Cramer says Eli Lilly has checked the most important box as obesity pill approval looms
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET....
-
🇺🇸 Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.
Employers can use Lilly's platform to connect with different third-party program administrators that help manage obesity treatment benefits and costs....
-
-
🇺🇸 These 4 charts show the scale of Novo Nordisk's woes
Despite being first to launch a GLP-1 drug for weight loss, Novo's market share has eroded, and the company now only captures about 40% of the market....
-
🇺🇸 Eli Lilly's lead in the obesity race gets wider after another win against rival Novo Nordisk
Lilly shares rose more than 4% Monday, while rival Novo Nordisk tanked....
-
🇺🇸 Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug....
-
🇺🇸 Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly's in trial
Novo Nordisk stock fell as much as 10% Monday after it said its next-generation weight loss drug didn't meet its primary target....
-
-
-
🇺🇸 Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study
Eli Lilly said on Wednesday the combined use of its weight-loss drug Zepbound with psoriasis treatment Taltz showed better results in a late-stage st...
-
🔗 Entity Intersection Graph
People and organizations frequently mentioned alongside Eli Lilly:
-
Food and Drug Administration · 12 shared articles -
Tirzepatide · 7 shared articles -
Novo Nordisk · 5 shared articles -
🌐
Ixekizumab · 3 shared articles
-
Psoriasis · 2 shared articles -
Delta Air Lines · 2 shared articles -
👤
Amazon Pharmacy · 2 shared articles
-
Semaglutide · 2 shared articles -
🌐
Combination therapy · 1 shared articles
-
🌐
Medicare · 1 shared articles